An official website of the United States government
NIH Guide: Weekly Index for December 24, 2021
Weekly NIH Funding Opportunities and Notices
December 24, 2021
General Notices
-
Notice of Pre-Application Webinar for RFA-DK-21-034, Analysis, Technology, Leadership, Administration and Science (ATLAS) Center (U24 Clinical Trial Not Allowed)
(NOT-DK-22-006)National Institute of Diabetes and Digestive and Kidney Diseases
-
RESCINDED - Notice of Clarification of Reporting Requirements for Animal Welfare Act Regulated Institutions, "Guidance on Flexibilities for Conducting Semiannual Inspections of Animal Facilities"
(NOT-OD-22-048)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice to Expire NOSIs to PAR-19-070, "Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)"
(NOT-AG-22-006)National Institute on Aging
-
Notice to Expire NOSIs to PAR-19-071, "Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)"
(NOT-AG-22-007)National Institute on Aging
-
Notice of NCI's Participation in PAR-20-070, "Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)"
(NOT-CA-22-023)National Cancer Institute
-
Notice to Extend the Response Date for NOT-CA-22-004 "Request for Information (RFI): Seeking Input on Technology Needs for Cancer Control and Population Sciences Researchers"
(NOT-CA-22-024)National Cancer Institute
-
Notice of NHLBI Participation in PAR-21-169 Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
(NOT-HL-21-042)National Heart, Lung, and Blood Institute
-
Notice of NHLBI Participation in PAR-21-173 - "Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)"
(NOT-HL-21-043)National Heart, Lung, and Blood Institute
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed)
(NOT-AR-22-015)National Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of Dental and Craniofacial ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative Health
Requests for Proposal
Notices of Special Interest
-
Notice of Special Interest: Research on Pain, Pain Management, and Opioids in Aging
(NOT-AG-22-004)National Institute on Aging
-
Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Pain, Pain Management, and Opioids in Aging
(NOT-AG-22-005)National Institute on Aging
-
Notice of Special Interest: NCCIH High Priority Pain Research
(NOT-AT-22-007)National Center for Complementary and Integrative Health
-
Notice of Special interest (NOSI): Medications Development for Stimulant Use Disorders
(NOT-DA-22-049)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Promoting Fundamental Research on Mitochondrial Involvement in Lung Diseases and Sleep Disorders
(NOT-HL-22-003)National Heart, Lung, and Blood Institute
-
Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection
(NOT-HL-22-004)National Heart, Lung, and Blood InstituteNational Institute of Allergy and Infectious DiseasesEunice Kennedy Shriver National Institute of Child Health and Human Development
-
RESCINDED - Notice of Special Interest (NOSI): Diagnostics and Disease Management Tools for Use in Underserved Populations
(NOT-HL-22-006)National Heart, Lung, and Blood Institute
-
Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed)
(NOT-HL-23-001)National Heart, Lung, and Blood InstituteNational Institute on AgingNational Cancer InstituteNational Institute of Environmental Health SciencesNational Human Genome Research InstituteNational Institute of Neurological Disorders and StrokeNational Institute on Minority Health and Health Disparities
-
RESCINDED - Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
(NOT-MD-22-006)National Institute on Minority Health and Health DisparitiesNational Institute of Allergy and Infectious DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Mental HealthNational Institute of Nursing ResearchOffice of Research on Women's HealthOffice of Behavioral and Social Sciences ResearchOffice of Disease Prevention
-
Notice of Special Interest (NOSI): NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional)
(NOT-MH-22-060)National Institute of Mental Health
-
RESCINDED - Notice of Special Interest (NOSI): Pain-Focused Administrative Supplements for NINDS Grants that are Not Focused on Pain Research
(NOT-NS-22-053)National Institute of Neurological Disorders and Stroke
Funding Opportunities
-
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional)
(PAR-22-077)National Institute on AgingApplication Receipt Date(s): February 15, 2024
-
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
(PAR-22-093)National Institute on AgingNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): November 12, 2024
-
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
(PAR-22-094)National Institute on AgingApplication Receipt Date(s): November 12, 2024
-
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
(PAS-22-096)National Institute of Diabetes and Digestive and Kidney DiseasesNational Institute on AgingNational Heart, Lung, and Blood InstituteApplication Receipt Date(s): December 10, 2024
-
Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)
(RFA-AG-23-003)National Institute on AgingApplication Receipt Date(s): March 03, 2022
-
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
(RFA-AI-21-079)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): June 3, 2022
-
HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed)
(RFA-DA-22-044)National Institute on Drug AbuseNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of Dental and Craniofacial ResearchNational Center for Complementary and Integrative HealthApplication Receipt Date(s): March 10, 2022
-
HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed)
(RFA-DA-22-045)National Institute on Drug AbuseNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of Dental and Craniofacial ResearchNational Center for Complementary and Integrative HealthApplication Receipt Date(s): March 10, 2022
-
PBPK Modeling to Support an Assessment of Bioequivalence for Locally-Acting Drugs in the Gastrointestinal Tract (U01) Clinical Trial Optional
(RFA-FD-22-012)Food and Drug AdministrationApplication Receipt Date(s): March 31, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
-
Physiologically Based Pharmacokinetic Model for Nose-to-Brain Drug Delivery (U01) Clinical Trial Optional
(RFA-FD-22-016)Food and Drug AdministrationApplication Receipt Date(s): May 18, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Cutaneous Pharmacokinetics (PK) Based Approaches to Demonstrate Bioequivalence of Topical Products (U01) Clinical Trial Required
(RFA-FD-22-017)Food and Drug AdministrationApplication Receipt Date(s): March 31, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
-
Building an Integrated Information Technology Infrastructure for State Regulatory Programs (U2F) [Clinical Trial Not Allowed]
(RFA-FD-22-021)Food and Drug AdministrationApplication Receipt Date(s): February 22, 2022
-
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
(RFA-MH-22-135)National Institute of Mental HealthNational Institute on AgingApplication Receipt Date(s): October 17, 2022
-
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
(RFA-MH-22-136)National Institute of Mental HealthNational Institute on AgingApplication Receipt Date(s): October 15, 2022
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: November 8, 2024
For technical issues E-mail OER Webmaster